Professional Documents
Culture Documents
Drug class
Antiepileptic
Therapeutic
actions
Mechanism of action
not understood:
antiepileptic activity
may be related to
the metabolism of
the inhibitory
neurotransmitter,
GABA; divalproex so
dium is a compound
containing equal
proportions
of valproic acid and
sodium valproate.
Indications
Sole and adjunctive
therapy in simple
(petit mal) and
complex absence
seizures
Depakote
ER: Treatment of
epilepsy in
children > 10 yr;
treatment of acute
manic or mixed
episodes associated
with bipolar disorder,
with or without
psychotic features
Adjunctive therapy
with multiple seizure
types, including
absence seizures
Depakote
ER: Treatment of
bipolar mania
Depakote, Depacote
ER: Prophylaxis of
migraine headaches
Divalproex, sodium
valproate
injection: Treatment
of complex partial
seizures as
monotherapy or with
other antiepileptics
Unlabeled uses:
Adjunct in symptom
management of
schizophrenia,
treatment of
aggressive outbursts
in children with
attention-deficit
hyperactivity
disorder, organic
brain syndrome
Contraindications
and cautions
Contraindicated with
hypersensitivity
to valproic acid,
hepatic disease or
significant hepatic
impairment.
Use cautiously with
children < 18 mo;
children < 2 yr,
especially with
multiple
antiepileptics,
congenital metabolic
disorders, severe
seizures
accompanied by
severe mental
retardation, organic
brain disorders
(higher risk of
developing
fatal hepatotoxicity);
pregnancy (fetal
Adverse effects
CNS: Sedation, trem
or (may be doserelated), emotional
upset, depression,
psychosis,
aggression,
hyperactivity,
behavioral
deterioration,
weakness
Dermatologic: Tran
sient increases in
hair loss,
rash, petechiae
GI: Nausea,
vomiting,
indigestion, diarrhea,
abdominal cramps,
constipation,
anorexia with weight
loss, increased
appetite with weight
gain, lifethreatening pancre
atitis, hepatic
failure
GU: Irregular
menses, secondary
amenorrhea
Hematologic: Slight
elevations in AST,
ALT, LDH; increases
in serum bilirubin,
abnormal changes in
Interactions
Drug-drug
Increased
serum phenobarbital,
primidone, ethosuxi
mide,
diazepam, zidovudin
e levels
Complex interactions
with phenytoin;
breakthrough
seizures have
occurred with the
combination
of valproic acid
and phenytoin
Increased serum
levels and toxicity
with salicylates, cime
tidine,
chlorpromazine,
erythromycin, felbam
ate
Decreased effects
with carbamazepine,
rifampin, lamotrigine
Decreased serum
levels with charcoal
Increased sedation
with alcohol, other
CNS depressants
Interventions
WARNING: Reduce
dosage, discontinue,
or substitute other
antiepileptics
gradually; abrupt
discontinuation of all
antiepileptics may
precipitate absence
seizures.
BLACK BOX
WARNING: Arrange
for frequent LFTs;
discontinue drug
immediately with
significant hepatic
impairment,
suspected or
apparent significant
hepatic impairment;
continue LFTs to
determine if hepatic
impairment
progresses in spite of
drug discontinuation.
WARNING: Arrange
for patient to have
platelet counts,
bleeding time
determination before
therapy, periodically
during therapy, and
prior to surgery.
Monitor patient
carefully for clotting
defects (bruising,
blood-tinged
toothbrush).
Discontinue if there
is evidence of
hemorrhage,
bruising, or disorder
ofhemostasis.
Monitor ammonia
levels, and
discontinue if there is
clinically significant
elevation in level.
Monitor serum levels
of valproic acid and
other antiepileptic
drugs given
concomitantly,
especially during the
first few weeks of
therapy. Adjust
dosage on the basis
of these data and
clinical response.
BLACK BOX
WARNING: Arrange
for counseling for
women of
childbearing age who
wish to become
pregnant; drug may
be teratogenic.
BLACK BOX
WARNING: Disconti
Teaching points
tablets may be
opened and sprinkled
on applesauce or
pudding.
Do not discontinue
this drug abruptly or
change dosage,
except on the advice
of your health care
provider.
Wear a medical ID
tag to alert
emergency medical
personnel that you
have epilepsy and
are taking
antiepileptic
medication.
If you have diabetes,
this drug may
toothbrush,
yellowing of the skin
or eyes, pale feces,
rash, pregnancy;
abdominal pain with
nausea, vomiting,
anorexia.
clozapine
tramadol
Applies to:clozapine
and
acetaminophen/tramado
l
TraMADol may cause
seizures, and combining
it with other
medications that can
Using cloZAPine
together with
clarithromycin may
increase the effects of
cloZAPine. Contact
your doctor if you
experience confusion,
fast heart rate,
drowsiness, drooling,
weak or shallow
lorazepam
risperidone
Applies to:Ativan
(lorazepam) and
risperidone
Using LORazepam
together with
risperiDONE may
increase side effects
such as dizziness,
drowsiness, and
difficulty concentrating.
Some people may also
experience some
impairment in thinking
and judgment. You
should avoid or limit
the use of alcohol while
being treated with these
medications. Avoid
driving or operating
hazardous machinery
until you know how the
medications affect you.
It is important to tell
your doctor about all
other medications you
use, including vitamins
and herbs. Do not stop
using any medications
Using propoxyphene
together with
risperiDONE may
increase side effects
such as dizziness,
drowsiness, confusion,
difficulty concentrating,
and other nervous
system or mental
effects. Some people,
treatment, following a
dose increase, or when
treatment is restarted
after an interruption.
Let your doctor know if
you develop these
symptoms and they do
not go away after a few
days or they become
troublesome. Avoid
driving or operating
hazardous machinery
until you know how the
medications affect you,
and use caution when
getting up from a sitting
or lying position. It is
important to tell your
doctor about all other
medications you use,
potassium chloride
biperiden
Applies to:K +
Potassium (potassium
chloride) and biperiden
The following
interaction applies only
if you are taking
potassium in a solid
formulation (i.E., tablet
or capsule swallowed
whole): Talk to your
effects of potassium on
your stomach and upper
intestine. This can
rarely result in ulcers,
bleeding, and other
gastrointestinal injury.
Contact your doctor
immediately if you
develop severe
abdominal pain,
bloating, sudden
dizziness or
lightheadedness,
nausea, vomiting
(especially with blood),
loss of appetite, and/or
black, tarry stools
during treatment with
these medications.
Alternatively, a liquid
formulation of
potassium may be
considered when used
in combination with
biperiden. It is
important to tell your
doctor about all other
medications you use,
including vitamins and
herbs. Do not stop
azatadine
biperiden
Applies to:azatadine
and biperiden
Using azatadine
together with biperiden
may increase side
effects such as
drowsiness, blurred
vision, dry mouth, heat
intolerance, flushing,
decreased sweating,
difficulty urinating,
abdominal cramping,
experience impairment
in thinking and
judgment. You should
avoid or limit the use of
alcohol while being
treated with these
medications. Do not use
more than the dosages
prescribed by your
doctor, and avoid
activities requiring
mental alertness such as
driving or operating
hazardous machinery
until you know how the
medication affects you.
It is important to tell
your doctor about all
other medications you
use, including vitamins